EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)

Potential for Maternally Administered Vaccine for Infant Group B Streptococcus

Shabir A Madhi iD, Annaliesa S Anderson, Judith Absalon, David Radley, Raphael Simon, Babalwa Jongihlati, Renate Strehlau, Anika M van Niekerk, Alane Izu, Niree Naidoo, Gaurav Kwatra, Yogandree Ramsamy und 15 weitere

New England Journal of Medicine · 20.07.2023 · 389 (3) · 215-227

DOI: 10.1056/nejmoa2116045 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift New England Journal of Medicine, erschienen am 20.07.2023. Verfasst von Shabir A Madhi und 26 weiteren Autor:innen. Beteiligte Einrichtung: From the South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit (S.A.M., R. Strehlau, A.I., G.K., S.J., L.J.…. Hauptthemen laut MEDLINE: Streptococcal Infections, Streptococcus agalactiae, Streptococcal Vaccines. Die Arbeit wurde bisher 160-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Bill and Melinda Gates Foundation, Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Streptococcal InfectionsStreptococcus agalactiaeStreptococcal VaccinesFemaleHumansInfantInfant, NewbornPregnancyAntibodies, BacterialImmunoglobulin GSeroepidemiologic StudiesVaccines, CombinedVaccines, ConjugateImmunity, Maternally-Acquired

Substanzen

Antibodies, BacterialImmunoglobulin GVaccines, CombinedVaccines, ConjugateStreptococcal Vaccines

Autor:innen und Institutionen

  • From the South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit (S.A.M., R. Strehlau, A.I., G.K., S.J., L.J.), the Department of Paediatrics and Child Health, Faculty of Health S…

ORCID-Profile: Shabir A Madhi

Förderung

  • Bill and Melinda Gates Foundation
  • Pfizer

Zitieren

APA

Madhi, S. A., Anderson, A. S., Absalon, J., Radley, D., Simon, R., Jongihlati, B., Strehlau, R., van Niekerk, A. M., Izu, A., Naidoo, N., Kwatra, G., Ramsamy, Y., Said, M., Jones, S., Jose, L., Fairlie, L., Barnabas, S. L., Newton, R., Munson, S., …, & Jansen, K. U. (2023). Potential for Maternally Administered Vaccine for Infant Group B Streptococcus. New England Journal of Medicine, 389(3), 215-227. https://doi.org/10.1056/nejmoa2116045

Vancouver

Madhi SA, Anderson AS, Absalon J, Radley D, Simon R, Jongihlati B, et al. Potential for Maternally Administered Vaccine for Infant Group B Streptococcus. New England Journal of Medicine. 2023;389(3):215-227. doi:10.1056/nejmoa2116045

BibTeX
@article{Madhi2023,
  author = {Madhi, Shabir A and Anderson, Annaliesa S and Absalon, Judith and Radley, David and Simon, Raphael and Jongihlati, Babalwa and Strehlau, Renate and van Niekerk, Anika M and Izu, Alane and Naidoo, Niree and Kwatra, Gaurav and Ramsamy, Yogandree and Said, Mohamed and Jones, Stephanie and Jose, Lisa and Fairlie, Lee and Barnabas, Shaun L and Newton, Ryan and Munson, Samantha and Jefferies, Zahra and Pavliakova, Danka and Silmon de Monerri, Natalie C and Gomme, Emily and Perez, John L and Scott, Daniel A and Gruber, William C and Jansen, Kathrin U},
  title = {Potential for Maternally Administered Vaccine for Infant Group B Streptococcus},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {389},
  number = {3},
  pages = {215--227},
  doi = {10.1056/nejmoa2116045}
}
Kostenlos starten →